{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:19:12Z","timestamp":1793045952776,"version":"4.5.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"crossref","award":["2023NSFSC0586"],"award-info":[{"award-number":["2023NSFSC0586"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"crossref","award":["2023NSFSC0586"],"award-info":[{"award-number":["2023NSFSC0586"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Sichuan University of Science and Engineering","award":["2021RC29"],"award-info":[{"award-number":["2021RC29"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-025-00704-5","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T07:57:30Z","timestamp":1747987050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective"],"prefix":"10.1186","volume":"17","author":[{"given":"Rania G.","family":"Elbaiomy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"El-Sappah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bakeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Elolimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Madkour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"704_CR1","unstructured":"Parikh NS, Ahlawat R: Helicobacter pylori. In: StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Rajni Ahlawat declares no relevant financial relationships with ineligible companies.: StatPearls Publishing. Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"key":"704_CR2","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.2147\/IDR.S383444","volume":"15","author":"H Xu","year":"2022","unstructured":"Xu H, Yun J, Li R, Ma X, Gou L, Che T, Zhang D. Antibiotics resistance prevalence of Helicobacter pylori strains in Northwest China. Infect Drug Resist. 2022;15:5519\u201328.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"704_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JK Hooi","year":"2017","unstructured":"Hooi JK, Lai WY, Ng WK, Suen MM, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VW, Wu JC. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420\u20139.","journal-title":"Gastroenterology"},{"issue":"1","key":"704_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41043-021-00280-9","volume":"41","author":"M Keikha","year":"2022","unstructured":"Keikha M, Sahebkar A, Yamaoka Y, Karbalaei M. Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis. J Health Popul Nutr. 2022;41(1):2.","journal-title":"J Health Popul Nutr"},{"key":"704_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.630852","volume":"12","author":"M Piscione","year":"2021","unstructured":"Piscione M, Mazzone M, Di Marcantonio MC, Muraro R, Mincione G. Eradication of Helicobacter pylori and gastric cancer: a controversial relationship. Front Microbiol. 2021;12: 630852.","journal-title":"Front Microbiol"},{"issue":"9","key":"704_CR6","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","volume":"64","author":"K Sugano","year":"2015","unstructured":"Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353\u201367.","journal-title":"Gut"},{"issue":"Suppl 8","key":"704_CR7","first-page":"72","volume":"89","author":"K Stefano","year":"2018","unstructured":"Stefano K, Marco M, Federica G, Laura B, Barbara B, Gioacchino L. Gian LdA: Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Bio Medica: Atenei Parmensis. 2018;89(Suppl 8):72.","journal-title":"Acta Bio Medica: Atenei Parmensis"},{"issue":"10","key":"704_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000180","volume":"4","author":"S Schwarz","year":"2008","unstructured":"Schwarz S, Morelli G, Kusecek B, Manica A, Balloux F, Owen RJ, Graham DY, van der Merwe S, Achtman M, Suerbaum S. Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog. 2008;4(10): e1000180.","journal-title":"PLoS Pathog"},{"issue":"34","key":"704_CR9","doi-asserted-by":"publisher","first-page":"13880","DOI":"10.1073\/pnas.1304681110","volume":"110","author":"X Didelot","year":"2013","unstructured":"Didelot X, Nell S, Yang I, Woltemate S, van der Merwe S, Suerbaum S. Genomic evolution and transmission of Helicobacter pylori in two South African families. Proc Natl Acad Sci USA. 2013;110(34):13880\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"704_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","volume":"18","author":"E Tshibangu-Kabamba","year":"2021","unstructured":"Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance\u2014from biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2021;18(9):613\u201329.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"704_CR11","volume-title":"Genomic characterisation and comparison of antibiotic resistant and sensitive Helicobacter pylori in New Zealand","author":"Z King","year":"2021","unstructured":"King Z. Genomic characterisation and comparison of antibiotic resistant and sensitive Helicobacter pylori in New Zealand. Auckland, New Zealand: Auckland University of Technology; 2021."},{"issue":"8","key":"704_CR12","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/AAC.00594-16","volume":"60","author":"CU Chukwudi","year":"2016","unstructured":"Chukwudi CU. rRNA binding sites and the molecular mechanism of action of the tetracyclines. Antimicrob Agents Chemother. 2016;60(8):4433\u201341.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"704_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s43088-023-00417-1","volume":"12","author":"TA Addissouky","year":"2023","unstructured":"Addissouky TA, Wang Y, El Sayed IET, Baz AE, Ali MM, Khalil AA. Recent trends in Helicobacter pylori management: harnessing the power of AI and other advanced approaches. Beni-Suef Univer J Basic Appl Sci. 2023;12(1):80.","journal-title":"Beni-Suef Univer J Basic Appl Sci"},{"issue":"8","key":"704_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/gut.2009.192757","volume":"59","author":"DY Graham","year":"2010","unstructured":"Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59(8):1143\u201353.","journal-title":"Gut"},{"issue":"4","key":"704_CR15","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.3346\/jkms.2024.39.e44","volume":"39","author":"M Hasanuzzaman","year":"2024","unstructured":"Hasanuzzaman M, Bang CS, Gong EJ. Antibiotic resistance of Helicobacter pylori: mechanisms and clinical implications. J Korean Med Sci. 2024;39(4):e44.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"704_CR16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology. 2018;155(5):1372\u201313821317.","journal-title":"Gastroenterology"},{"issue":"7","key":"704_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24885","volume":"37","author":"Y Lin","year":"2023","unstructured":"Lin Y, Shao Y, Yan J, Ye G. Antibiotic resistance in Helicobacter pylori: from potential biomolecular mechanisms to clinical practice. J Clin Lab Anal. 2023;37(7): e24885.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"704_CR18","first-page":"8","volume":"4","author":"N Rodis","year":"2020","unstructured":"Rodis N, Tsapadikou V, Potsios C, Xaplanteri P. Resistance mechanisms in bacterial biofilm formations: a review. J Emerg Intern Med. 2020;4(1):8.","journal-title":"J Emerg Intern Med"},{"key":"704_CR19","first-page":"1","volume":"51","author":"Z Umar","year":"2024","unstructured":"Umar Z, Tang J-W, Marshall BJ, Tay ACY, Wang L. Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings. Crit Rev Microbiol. 2024;51:1\u201330.","journal-title":"Crit Rev Microbiol"},{"issue":"12","key":"704_CR20","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","volume":"69","author":"JM Liou","year":"2020","unstructured":"Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, Yeoh KG, Hsu PI, Goh KL, Mahachai V, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020;69(12):2093\u2013112.","journal-title":"Gut"},{"issue":"9","key":"704_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3390\/children9091359","volume":"9","author":"R Borka Balas","year":"2022","unstructured":"Borka Balas R, Meli\u021b LE, M\u0103rginean CO. Worldwide prevalence and risk factors of Helicobacter pylori infection in children. Children. 2022;9(9):1359.","journal-title":"Children"},{"issue":"6","key":"704_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol hepatol. 2023;8(6):553\u201364.","journal-title":"Lancet Gastroenterol hepatol"},{"issue":"4","key":"704_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","volume":"166","author":"Y-C Chen","year":"2024","unstructured":"Chen Y-C, Malfertheiner P, Yu H-T, Kuo C-L, Chang Y-Y, Meng F-T, Wu Y-X, Hsiao J-L, Chen M-J, Lin K-P. Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology. 2024;166(4):605\u201319.","journal-title":"Gastroenterology"},{"key":"704_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12038-020-00078-7","volume":"45","author":"A Saxena","year":"2020","unstructured":"Saxena A, Mukhopadhyay AK, Nandi SP. Helicobacter pylori: perturbation and restoration of gut microbiome. J Biosci. 2020;45:1\u201315.","journal-title":"J Biosci"},{"key":"704_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2352-4642(21)00400-4","volume":"6","author":"C Yuan","year":"2022","unstructured":"Yuan C, Adeloye D, Luk TT, Huang L, He Y, Xu Y, Ye X, Yi Q, Song P, Rudan I. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolescent Health. 2022;6:185\u201394.","journal-title":"Lancet Child Adolescent Health"},{"issue":"9","key":"704_CR26","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","volume":"71","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou J-M, Schulz C, Gasbarrini A, Hunt RH, Leja M, O\u2019Morain C. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut. 2022;71(9):1724\u201362.","journal-title":"Gut"},{"issue":"2","key":"704_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5009\/gnl20288","volume":"15","author":"HK Jung","year":"2021","unstructured":"Jung HK, Kang SJ, Lee YC, Yang HJ, Park SY, Shin CM, Kim SE, Lim HC, Kim JH, Nam SY, et al. Evidence-based guidelines for the treatment of Helicobacter pylori Infection in Korea 2020. Gut Liver. 2021;15(2):168\u201395.","journal-title":"Gut Liver"},{"issue":"4","key":"704_CR28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, Gupta S, Park J, Crowe S, Valasek M. the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43(4):514\u201333.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"704_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12939","volume":"28","author":"JW Lee","year":"2023","unstructured":"Lee JW, Kim N, Choi SI, Jang JY, Song CH, Nam RH, Lee DH. Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea. Helicobacter. 2023;28(1): e12939.","journal-title":"Helicobacter"},{"issue":"8","key":"704_CR30","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.14309\/ajg.0000000000001828","volume":"117","author":"JJC Ho","year":"2022","unstructured":"Ho JJC, Navarro M, Sawyer K, Elfanagely Y, Moss SF. Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: a systematic review and meta-analysis. Am J Gastroenterol. 2022;117(8):1221\u201330.","journal-title":"Am J Gastroenterol"},{"issue":"15","key":"704_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1056\/NEJMra020542","volume":"347","author":"S Suerbaum","year":"2002","unstructured":"Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347(15):1175\u201386.","journal-title":"N Engl J Med"},{"key":"704_CR32","doi-asserted-by":"publisher","first-page":"539115","DOI":"10.3389\/fcimb.2020.539115","volume":"10","author":"M Camorlinga-Ponce","year":"2021","unstructured":"Camorlinga-Ponce M, G\u00f3mez-Delgado A, Aguilar-Zamora E, Torres RC, Giono-Cerezo S, Escobar-Ogaz A, Torres J. Phenotypic and genotypic antibiotic resistance patterns in Helicobacter pylori strains from ethnically diverse population in M\u00e9xico. Front Cell Infect Microbiol. 2021;10:539115.","journal-title":"Front Cell Infect Microbiol"},{"key":"704_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-1158","volume":"13","author":"KV Nguyen","year":"2013","unstructured":"Nguyen KV, Thi Do NT, Chandna A, Nguyen TV, Pham CV, Doan PM, Nguyen AQ, Thi Nguyen CK, Larsson M, Escalante S. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health. 2013;13:1\u201310.","journal-title":"BMC Public Health"},{"key":"704_CR34","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2147\/IDR.S250200","volume":"13","author":"GG Kasahun","year":"2020","unstructured":"Kasahun GG, Demoz GT, Desta DM. Primary resistance pattern of Helicobacter pylori to antibiotics in adult population: a systematic review. Infect Drug Resist. 2020;13:1567\u201373.","journal-title":"Infect Drug Resist"},{"key":"704_CR35","first-page":"3S","volume":"63","author":"M Ballal","year":"2016","unstructured":"Ballal M. Trends in antimicrobial resistance among enteric pathogens: a global concern. Antibiotic Resis. 2016;63:3S-8S.","journal-title":"Antibiotic Resis"},{"key":"704_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.healthplace.2018.07.004","volume":"53","author":"A M\u00f6lter","year":"2018","unstructured":"M\u00f6lter A, Belmonte M, Palin V, Mistry C, Sperrin M, White A, Welfare W, Van Staa T. Antibiotic prescribing patterns in general medical practices in England: does area matter? Health Place. 2018;53:10\u20136.","journal-title":"Health Place"},{"key":"704_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11908-018-0634-9","volume":"20","author":"KL Schwartz","year":"2018","unstructured":"Schwartz KL, Morris SK. Travel and the spread of drug-resistant bacteria. Current Infect Dis Rep. 2018;20:1\u201310.","journal-title":"Current Infect Dis Rep"},{"issue":"4","key":"704_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002418","volume":"5","author":"MJ Loftus","year":"2020","unstructured":"Loftus MJ, Stewardson AJ, Naidu R, Coghlan B, Jenney AW, Kepas J, Lavu E, Munamua AB, Peel TN, Sahai V. Antimicrobial resistance in the Pacific Island countries and territories. BMJ Glob Health. 2020;5(4): e002418.","journal-title":"BMJ Glob Health"},{"issue":"11","key":"704_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1473-3099(06)70627-2","volume":"6","author":"MM Gerrits","year":"2006","unstructured":"Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis. 2006;6(11):699\u2013709.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"704_CR40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168(4):707\u201323.","journal-title":"Cell"},{"key":"704_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13613-016-0199-4","volume":"6","author":"G Zilahi","year":"2016","unstructured":"Zilahi G, Artigas A, Martin-Loeches I. What\u2019s new in multidrug-resistant pathogens in the ICU? Ann Intensive Care. 2016;6:1\u201311.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"704_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/femsre\/fuaa001","volume":"44","author":"DI Andersson","year":"2020","unstructured":"Andersson DI, Balaban NQ, Baquero F, Courvalin P, Glaser P, Gophna U, Kishony R, Molin S, T\u00f8njum T. Antibiotic resistance: turning evolutionary principles into clinical reality. FEMS Microbiol Rev. 2020;44(2):171\u201388.","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"704_CR43","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.4269\/ajtmh.17-0478","volume":"98","author":"M L\u00f3pez-Gasca","year":"2018","unstructured":"L\u00f3pez-Gasca M, Pe\u00f1a J, Garc\u00eda-Amado MA, Michelangeli F, Contreras M. Point Mutations at gyrA and gyrB Genes of Levofloxacin-Resistant Helicobacter pylori Isolates in the Esophageal Mucosa from a Venezuelan Population. Am J Trop Med Hyg. 2018;98(4):1051\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"704_CR44","doi-asserted-by":"publisher","first-page":"001333","DOI":"10.1099\/mic.0.001333","volume":"169","author":"A Gaurav","year":"2023","unstructured":"Gaurav A, Bakht P, Saini M, Pandey S, Pathania R. Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. Microbiology. 2023;169(5):001333.","journal-title":"Microbiology"},{"issue":"19","key":"704_CR45","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1128\/jb.175.19.6299-6313.1993","volume":"175","author":"D Ma","year":"1993","unstructured":"Ma D, Cook D, Alberti M, Pon N, Nikaido H, Hearst J. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol. 1993;175(19):6299\u2013313.","journal-title":"J Bacteriol"},{"issue":"8","key":"704_CR46","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1128\/AAC.38.8.1732","volume":"38","author":"X-Z Li","year":"1994","unstructured":"Li X-Z, Livermore DM, Nikaido H. Role of efflux pump (s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother. 1994;38(8):1732\u201341.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"704_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","volume":"28","author":"XZ Li","year":"2015","unstructured":"Li XZ, Pl\u00e9siat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015;28(2):337\u2013418.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"704_CR48","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1128\/AAC.49.4.1477-1482.2005","volume":"49","author":"K van Amsterdam","year":"2005","unstructured":"van Amsterdam K, Bart A, van der Ende A. A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Chemother. 2005;49(4):1477\u201382.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"704_CR49","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2217\/fmb.14.66","volume":"9","author":"JM Blair","year":"2014","unstructured":"Blair JM, Richmond GE, Piddock LJ. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol. 2014;9(10):1165\u201377.","journal-title":"Future Microbiol"},{"issue":"2","key":"704_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","volume":"149","author":"A Sharma","year":"2019","unstructured":"Sharma A, Gupta VK, Pathania R. Efflux pump inhibitors for bacterial pathogens: from bench to bedside. Indian J Med Res. 2019;149(2):129\u201345.","journal-title":"Indian J Med Res"},{"issue":"2","key":"704_CR51","first-page":"237","volume":"4","author":"YJ Chung","year":"2001","unstructured":"Chung YJ, Saier M Jr. SMR-type multidrug resistance pumps. Curr Opin Drug Discov Devel. 2001;4(2):237\u201345.","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"1","key":"704_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6976.1998.tb00358.x","volume":"22","author":"E Schneider","year":"1998","unstructured":"Schneider E, Hunke S. ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits\/domains. FEMS Microbiol Rev. 1998;22(1):1\u201320.","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"704_CR53","doi-asserted-by":"publisher","first-page":"e30726","DOI":"10.5812\/jjm.30726","volume":"9","author":"T Falsafi","year":"2016","unstructured":"Falsafi T, Ehsani A, Attaran B, Niknam V. Association of hp1181 and hp1184 genes with the active efflux phenotype in multidrug-resistant isolates of Helicobacter pylori. Jundishapur J Microbiol. 2016;9(4):e30726.","journal-title":"Jundishapur J Microbiol"},{"key":"704_CR54","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.matpr.2020.11.955","volume":"45","author":"DS Raj","year":"2021","unstructured":"Raj DS, Kesavan DK, Muthusamy N, Umamaheswari S. Efflux pumps potential drug targets to circumvent drug Resistance-Multi drug efflux pumps of Helicobacter pylori. Mater Today Proceed. 2021;45:2976\u201381.","journal-title":"Mater Today Proceed"},{"key":"704_CR55","doi-asserted-by":"publisher","first-page":"e24885","DOI":"10.1002\/jcla.24885","volume":"37","author":"Y Lin","year":"2023","unstructured":"Lin Y, Shao Y, Yan J, Ye G. Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice. J Clin Laborat Analys. 2023;37:e24885.","journal-title":"J Clin Laborat Analys"},{"issue":"4","key":"704_CR56","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","volume":"23","author":"LE Wroblewski","year":"2010","unstructured":"Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713\u201339.","journal-title":"Clin Microbiol Rev"},{"key":"704_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2023.105459","volume":"112","author":"MN Hajiagha","year":"2023","unstructured":"Hajiagha MN, Kafil HS. Efflux pumps and microbial biofilm formation. Infect Genet Evol. 2023;112: 105459.","journal-title":"Infect Genet Evol"},{"key":"704_CR58","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00957-00918","author":"X Ge","year":"2018","unstructured":"Ge X, Cai Y, Chen Z, Gao S, Geng X, Li Y, Li Y, Jia J, Sun Y. Bifunctional enzyme SpoT Is involved in biofilm formation of Helicobacter pylori with multidrug resistance by upregulating efflux pump Hp1174 (gluP). Antimicrob Agents Chemotherapy. 2018. https:\/\/doi.org\/10.1128\/aac.00957-00918.","journal-title":"Antimicrob Agents Chemotherapy"},{"issue":"3","key":"704_CR59","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","volume":"4","author":"WC Reygaert","year":"2018","unstructured":"Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018;4(3):482.","journal-title":"AIMS Microbiol"},{"issue":"8","key":"704_CR60","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro1464","volume":"4","author":"LJV Piddock","year":"2006","unstructured":"Piddock LJV. Multidrug-resistance efflux pumps\u202f? not just for resistance. Nat Rev Microbiol. 2006;4(8):629\u201336.","journal-title":"Nat Rev Microbiol"},{"key":"704_CR61","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00367-00320","author":"T Teelucksingh","year":"2020","unstructured":"Teelucksingh T, Thompson LK, Cox G. The evolutionary conservation of Escherichia coli drug efflux pumps supports physiological functions. J Bacteriol. 2020. https:\/\/doi.org\/10.1128\/jb.00367-00320.","journal-title":"J Bacteriol"},{"key":"704_CR62","first-page":"1","volume":"40","author":"I Ahmad","year":"2024","unstructured":"Ahmad I, Ali M, Ali R, Nawaz N, Patching SG. Multidrug efflux protein families in bacteria: ABC, RND, MFS, SMR, MATE, PACE, AbgT (An Update). Biochemistry. 2024;40:1\u201332.","journal-title":"Biochemistry"},{"key":"704_CR63","doi-asserted-by":"crossref","unstructured":"Koehn LM: ABC transporters: an overview. The ADME encyclopedia: a comprehensive guide on biopharmacy and pharmacokinetics 2022","DOI":"10.1007\/978-3-030-84860-6_76"},{"issue":"6","key":"704_CR64","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3748\/wjg.v20.i6.1402","volume":"20","author":"G Zanotti","year":"2014","unstructured":"Zanotti G, Cendron L. Structural and functional aspects of the Helicobacter pylori secretome. World J Gastroenterol: WJG. 2014;20(6):1402.","journal-title":"World J Gastroenterol: WJG"},{"issue":"2","key":"704_CR65","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbrc.2014.05.090","volume":"453","author":"J Sun","year":"2014","unstructured":"Sun J, Deng Z, Yan A. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem Biophys Res Commun. 2014;453(2):254\u201367.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"704_CR66","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1128\/AAC.45.6.1761-1770.2001","volume":"45","author":"TR De Kievit","year":"2001","unstructured":"De Kievit TR, Parkins MD, Gillis RJ, Srikumar R, Ceri H, Poole K, Iglewski BH, Storey DG. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2001;45(6):1761\u201370.","journal-title":"Antimicrob Agents Chemother"},{"key":"704_CR67","doi-asserted-by":"crossref","unstructured":"Yamasaki S, Wang LiYuan WL, Hirata T, Hayashi-Nishino M, Nishino K: Multidrug efflux pumps contribute to Escherichia coli biofilm maintenance. 2015.","DOI":"10.1016\/j.ijantimicag.2014.12.005"},{"issue":"3","key":"704_CR68","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4161\/viru.23724","volume":"4","author":"SM Soto","year":"2013","unstructured":"Soto SM. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence. 2013;4(3):223\u20139.","journal-title":"Virulence"},{"issue":"9","key":"704_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073301","volume":"8","author":"H Yonezawa","year":"2013","unstructured":"Yonezawa H, Osaki T, Hanawa T, Kurata S, Ochiai K, Kamiya S. Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations. PLoS ONE. 2013;8(9): e73301.","journal-title":"PLoS ONE"},{"issue":"6642","key":"704_CR70","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/41483","volume":"388","author":"J-F Tomb","year":"1997","unstructured":"Tomb J-F, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997;388(6642):539\u201347.","journal-title":"Nature"},{"issue":"1","key":"704_CR71","doi-asserted-by":"publisher","first-page":"2379439","DOI":"10.1080\/19490976.2024.2379439","volume":"16","author":"X Gong","year":"2024","unstructured":"Gong X, Wang Y, An Y, Li Z, Liu D, Yong X. The crosstalk between efflux pump and resistance gene mutation in Helicobacter pylori. Gut microbes. 2024;16(1):2379439.","journal-title":"Gut microbes"},{"issue":"7","key":"704_CR72","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/antibiotics12071118","volume":"12","author":"RI Alfaray","year":"2023","unstructured":"Alfaray RI, Saruuljavkhlan B, Fauzia KA, Torres RC, Thorell K, Dewi SR, Kryukov KA, Matsumoto T, Akada J. Vilaichone R-k: Global antimicrobial resistance gene study of Helicobacter pylori: comparison of detection tools, ARG and efflux pump gene analysis, worldwide epidemiological distribution, and information related to the antimicrobial-resistant phenotype. Antibiotics. 2023;12(7):1118.","journal-title":"Antibiotics"},{"key":"704_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.868905","volume":"12","author":"P Krzy\u017cek","year":"2022","unstructured":"Krzy\u017cek P, Migda\u0142 P, Grande R, Go\u015bciniak G. Biofilm formation of Helicobacter pylori in both static and microfluidic conditions is associated with resistance to clarithromycin. Front Cell Infect Microbiol. 2022;12: 868905.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"704_CR74","doi-asserted-by":"publisher","first-page":"102443","DOI":"10.1016\/j.isci.2021.102443","volume":"24","author":"I Guzm\u00e1n-Soto","year":"2021","unstructured":"Guzm\u00e1n-Soto I, McTiernan C, Gonzalez-Gomez M, Ross A, Gupta K, Suuronen EJ, Mah TF, Griffith M, Alarcon EI. Mimicking biofilm formation and development: recent progress in in\u00a0vitro and in\u00a0vivo biofilm models. iScience. 2021;24(5):102443.","journal-title":"iScience"},{"issue":"1","key":"704_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-020-00830-6","volume":"9","author":"P Bowler","year":"2020","unstructured":"Bowler P, Murphy C, Wolcott R. Biofilm exacerbates antibiotic resistance: Is this a current oversight in antimicrobial stewardship? Antimicrob Resist Infect Control. 2020;9(1):1\u20135.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"704_CR76","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41522-021-00251-2","volume":"7","author":"A Penesyan","year":"2021","unstructured":"Penesyan A, Paulsen IT, Kjelleberg S, Gillings MR. Three faces of biofilms: a microbial lifestyle, a nascent multicellular organism, and an incubator for diversity. Npj Biofilms Microbiom. 2021;7(1):80.","journal-title":"Npj Biofilms Microbiom"},{"issue":"1","key":"704_CR77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41522-020-00183-3","volume":"7","author":"H-C Flemming","year":"2021","unstructured":"Flemming H-C, Baveye P, Neu TR, Stoodley P, Szewzyk U, Wingender J, Wuertz S. Who put the film in biofilm? The migration of a term from wastewater engineering to medicine and beyond. Npj Biofilms Microbiom. 2021;7(1):10.","journal-title":"Npj Biofilms Microbiom"},{"issue":"1","key":"704_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcma.2017.07.012","volume":"81","author":"M Jamal","year":"2018","unstructured":"Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Rafiq M, Kamil MA. Bacterial biofilm and associated infections. J Chin Med Associat. 2018;81(1):7\u201311.","journal-title":"J Chin Med Associat"},{"issue":"10","key":"704_CR79","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41579-020-0385-0","volume":"18","author":"KP Rumbaugh","year":"2020","unstructured":"Rumbaugh KP, Sauer K. Biofilm dispersion. Nat Rev Microbiol. 2020;18(10):571\u201386.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"704_CR80","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","volume":"41","author":"CW Hall","year":"2017","unstructured":"Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41(3):276\u2013301.","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"704_CR81","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s13205-021-02707-w","volume":"11","author":"J Khan","year":"2021","unstructured":"Khan J, Tarar SM, Gul I, Nawaz U, Arshad M. Challenges of antibiotic resistance biofilms and potential combating strategies: a review. 3 Biotech. 2021;11(4):169.","journal-title":"3 Biotech"},{"issue":"2","key":"704_CR82","doi-asserted-by":"publisher","first-page":"022003","DOI":"10.1088\/1748-605X\/ac50f6","volume":"17","author":"A Singh","year":"2022","unstructured":"Singh A, Amod A, Pandey P, Bose P, Pingali MS, Shivalkar S, Varadwaj PK, Sahoo AK, Samanta SK. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies. Biomed Mater. 2022;17(2):022003.","journal-title":"Biomed Mater"},{"issue":"4","key":"704_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002626","volume":"8","author":"C Pozzi","year":"2012","unstructured":"Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, Loftus BJ, Pier GB, Fey PD, Massey RC, et al. Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. PLoS Pathog. 2012;8(4): e1002626.","journal-title":"PLoS Pathog"},{"issue":"1","key":"704_CR84","first-page":"10","volume":"4","author":"EG Dominguez","year":"2019","unstructured":"Dominguez EG, Zarnowski R, Choy HL, Zhao M, Sanchez H, Nett JE, Andes DR. Conserved role for biofilm matrix polysaccharides in candida auris drug resistance. Sphere. 2019;4(1):10\u2013128.","journal-title":"Sphere"},{"key":"704_CR85","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13756-016-0104-9","volume":"5","author":"S Neupane","year":"2016","unstructured":"Neupane S, Pant ND, Khatiwada S, Chaudhary R, Banjara MR. Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu. Nepal Antimicrobial Resist Infect Control. 2016;5:5.","journal-title":"Nepal Antimicrobial Resist Infect Control"},{"key":"704_CR86","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2147\/IDR.S303992","volume":"14","author":"SA Senobar Tahaei","year":"2021","unstructured":"Senobar Tahaei SA, St\u00e1jer A, Barrak I, Ostorh\u00e1zi E, Szab\u00f3 D, Gajd\u00e1cs M. Correlation between biofilm-formation and the antibiotic resistant phenotype in Staphylococcus aureus isolates: a laboratory-based study in hungary and a review of the literature. Infect Drug Resist. 2021;14:1155\u201368.","journal-title":"Infect Drug Resist"},{"key":"704_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.735494","volume":"12","author":"T Saber","year":"2021","unstructured":"Saber T, Samir M, El-Mekkawy RM, Ariny E, El-Sayed SR, Enan G, Abdelatif SH, Askora A, Merwad AMA, Tartor YH. Methicillin- and vancomycin-resistant Staphylococcus aureus from humans and ready-to-eat meat: characterization of antimicrobial resistance and biofilm formation ability. Front Microbiol. 2021;12: 735494.","journal-title":"Front Microbiol"},{"key":"704_CR88","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.micpath.2017.04.039","volume":"108","author":"AM Bardbari","year":"2017","unstructured":"Bardbari AM, Arabestani MR, Karami M, Keramat F, Alikhani MY, Bagheri KP. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates. Microb Pathog. 2017;108:122\u20138.","journal-title":"Microb Pathog"},{"issue":"1","key":"704_CR89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12941-017-0194-0","volume":"16","author":"A Belbase","year":"2017","unstructured":"Belbase A, Pant ND, Nepal K, Neupane B, Baidhya R, Baidya R, Lekhak B. Antibiotic resistance and biofilm production among the strains of Staphylococcus aureus isolated from pus\/wound swab samples in a tertiary care hospital in Nepal. Ann Clin Microbiol Antimicrob. 2017;16(1):15.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"11","key":"704_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259584","volume":"16","author":"MA El-Zamkan","year":"2021","unstructured":"El-Zamkan MA, Mohamed HMA. Antimicrobial resistance, virulence genes and biofilm formation in Enterococcus species isolated from milk of sheep and goat with subclinical mastitis. PLoS ONE. 2021;16(11): e0259584.","journal-title":"PLoS ONE"},{"issue":"2","key":"704_CR91","doi-asserted-by":"publisher","first-page":"306","DOI":"10.26444\/aaem\/122682","volume":"28","author":"M Ratajczak","year":"2021","unstructured":"Ratajczak M, Kami\u0144ska D, Nowak-Malczewska DM, Schneider A, Dlugaszewska J. Relationship between antibiotic resistance, biofilm formation, genes coding virulence factors and source of origin of Pseudomonas aeruginosa clinical strains. Annals Agric Environ Med. 2021;28(2):306\u201313.","journal-title":"Annals Agric Environ Med"},{"key":"704_CR92","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00001-00018","author":"S Hathroubi","year":"2018","unstructured":"Hathroubi S, Servetas SL, Windham I, Merrell DS, Ottemann KM. Helicobacter pylori biofilm formation and its potential role in pathogenesis. Microbio Mol Bio Rev. 2018. https:\/\/doi.org\/10.1128\/mmbr.00001-00018.","journal-title":"Microbio Mol Bio Rev"},{"issue":"5","key":"704_CR93","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1365-2672.2007.03287.x","volume":"102","author":"S Macfarlane","year":"2007","unstructured":"Macfarlane S, Dillon JF. Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol. 2007;102(5):1187\u201396.","journal-title":"J Appl Microbiol"},{"issue":"5","key":"704_CR94","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41575-020-00397-y","volume":"18","author":"JP Motta","year":"2021","unstructured":"Motta JP, Wallace JL, Buret AG, Deraison C, Vergnolle N. Gastrointestinal biofilms in health and disease. Nat Rev Gastroenterol Hepatol. 2021;18(5):314\u201334.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"704_CR95","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/pathogens9121062","volume":"9","author":"P Krzy\u017cek","year":"2020","unstructured":"Krzy\u017cek P, Grande R, Migda\u0142 P, Paluch E, Go\u015bciniak G. Biofilm formation as a complex result of virulence and adaptive responses of Helicobacter pylori. Pathogens. 2020;9(12):1062.","journal-title":"Pathogens"},{"issue":"7","key":"704_CR96","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3748\/wjg.v23.i7.1163","volume":"23","author":"B Attaran","year":"2017","unstructured":"Attaran B, Falsafi T, Ghorbanmehr N. Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics. World J Gastroenterol. 2017;23(7):1163\u201370.","journal-title":"World J Gastroenterol"},{"key":"704_CR97","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.micpath.2019.04.030","volume":"132","author":"H Yonezawa","year":"2019","unstructured":"Yonezawa H, Osaki T, Hojo F, Kamiya S. Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin. Microb Pathog. 2019;132:100\u20138.","journal-title":"Microb Pathog"},{"issue":"4","key":"704_CR98","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12715","volume":"25","author":"Y Cai","year":"2020","unstructured":"Cai Y, Wang C, Chen Z, Xu Z, Li H, Li W, Sun Y. Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux. Helicobacter. 2020;25(4): e12715.","journal-title":"Helicobacter"},{"issue":"8","key":"704_CR99","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/toxins12080473","volume":"12","author":"KA Fauzia","year":"2020","unstructured":"Fauzia KA, Miftahussurur M, Syam AF, Waskito LA, Doohan D, Rezkitha YAA, Matsumoto T, Tuan VP, Akada J, Yonezawa H, et al. Biofilm formation and antibiotic resistance phenotype of Helicobacter pylori clinical isolates. Toxins. 2020;12(8):473.","journal-title":"Toxins"},{"issue":"14","key":"704_CR100","doi-asserted-by":"publisher","first-page":"e00391","DOI":"10.1128\/AEM.00391-18","volume":"84","author":"IH Windham","year":"2018","unstructured":"Windham IH, Servetas SL, Whitmire JM, Pletzer D, Hancock RE, Merrell DS. Helicobacter pylori biofilm formation is differentially affected by common culture conditions, and proteins play a central role in the biofilm matrix. Appl Environ Microbiol. 2018;84(14):e00391-e1318.","journal-title":"Appl Environ Microbiol"},{"key":"704_CR101","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01973-01918","author":"S Hathroubi","year":"2018","unstructured":"Hathroubi S, Zerebinski J, Ottemann Karen M. Helicobacter pylori biofilm involves a multigene stress-biased response, including a structural role for flagella. MBio. 2018. https:\/\/doi.org\/10.1128\/mbio.01973-01918.","journal-title":"MBio"},{"key":"704_CR102","doi-asserted-by":"publisher","first-page":"1477317","DOI":"10.3389\/fphar.2024.1477317","volume":"15","author":"P Krzy\u017cek","year":"2024","unstructured":"Krzy\u017cek P, Migda\u0142 P, Tusiewicz K, Zawadzki M, Szpot P. Subinhibitory concentrations of antibiotics affect development and parameters of Helicobacter pylori biofilm. Front Pharmacol. 2024;15:1477317.","journal-title":"Front Pharmacol"},{"issue":"2","key":"704_CR103","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1574-695X.2009.00556.x","volume":"56","author":"LP Andersen","year":"2009","unstructured":"Andersen LP, Rasmussen L. Helicobacter pylori-coccoid forms and biofilm formation. FEMS Immunol Med Microbiol. 2009;56(2):112\u20135.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"12","key":"704_CR104","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0934-8840(11)80964-3","volume":"280","author":"M Nilius","year":"1993","unstructured":"Nilius M, Str\u00f6hle A, Bode G, Malfertheiner P. Coccoid like forms (CLF) of Helicobacter pylori Enzyme activity and antigenicity. Zentralblatt fur Bakteriologie. 1993;280(12):259\u201372.","journal-title":"Zentralblatt fur Bakteriologie"},{"issue":"6","key":"704_CR105","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1128\/iai.64.6.2331-2335.1996","volume":"64","author":"M Benaissa","year":"1996","unstructured":"Benaissa M, Babin P, Quellard N, Pezennec L, Cenatiempo Y, Fauch\u00e8re JL. Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid form. Infect Immun. 1996;64(6):2331\u20135.","journal-title":"Infect Immun"},{"issue":"1","key":"704_CR106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/jinf.2002.1047","volume":"46","author":"N Saito","year":"2003","unstructured":"Saito N, Konishi K, Sato F, Kato M, Takeda H, Sugiyama T, Asaka M. Plural transformation-processes from spiral to coccoid Helicobacter pylori and its viability. J Infect. 2003;46(1):49\u201355.","journal-title":"J Infect"},{"issue":"3","key":"704_CR107","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12223-018-0665-5","volume":"64","author":"P Krzy\u017cek","year":"2019","unstructured":"Krzy\u017cek P, Biernat MM, Go\u015bciniak G. Intensive formation of coccoid forms as a feature strongly associated with highly pathogenic Helicobacter pylori strains. Folia Microbiol. 2019;64(3):273\u201381.","journal-title":"Folia Microbiol"},{"issue":"3","key":"704_CR108","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/jcp.45.3.228","volume":"45","author":"AP West","year":"1992","unstructured":"West AP, Millar MR, Tompkins DS. Effect of physical environment on survival of Helicobacter pylori. J Clin Pathol. 1992;45(3):228\u201331.","journal-title":"J Clin Pathol"},{"issue":"Suppl XVII","key":"704_CR109","first-page":"62","volume":"67","author":"M Shahamat","year":"1989","unstructured":"Shahamat M, Paszko-Kolva C, Yamamoto H, Colwell R. Ecological studies of Campylobacter pylori. Klin Wochenschr. 1989;67(Suppl XVII):62\u20133.","journal-title":"Klin Wochenschr"},{"issue":"11","key":"704_CR110","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1600-0643.2007.00594.x","volume":"115","author":"K Konishi","year":"2007","unstructured":"Konishi K, Saito N, Shoji E, Takeda H, Kato M, Asaka M. OOI HK: Helicobacter pylori: longer survival in deep ground water and sea water than in a nutrient-rich environment. APMIS. 2007;115(11):1285\u201391.","journal-title":"APMIS"},{"issue":"8","key":"704_CR111","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1128\/AAC.39.8.1859","volume":"39","author":"V Berry","year":"1995","unstructured":"Berry V, Jennings K, Woodnutt G. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob Agents Chemother. 1995;39(8):1859\u201361.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"704_CR112","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0924-8579(00)00188-6","volume":"15","author":"F Sisto","year":"2000","unstructured":"Sisto F, Brenciaglia M, Scaltrito M, Dubini F. Helicobacter pylori: ureA, cagA and vacA expression during conversion to the coccoid form. Int J Antimicrob Agents. 2000;15(4):277\u201382.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"704_CR113","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1017\/S0950268800057216","volume":"111","author":"G Bode","year":"1993","unstructured":"Bode G, Mauch F, Malfertheiner P. The coccoid forms of Helicobacter pylori Criteria for their viability. Epidemiol Infect. 1993;111(3):483\u201390.","journal-title":"Epidemiol Infect"},{"issue":"11","key":"704_CR114","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1128\/AAC.43.11.2702","volume":"43","author":"CR DeLoney","year":"1999","unstructured":"DeLoney CR, Schiller NL. Competition of various \u03b2-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology. Antimicrob Agents Chemother. 1999;43(11):2702\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"704_CR115","first-page":"353","volume":"27","author":"B Citterio","year":"2004","unstructured":"Citterio B, Casaroli A, Pierfelici L, Battistelli M, Falcieri E, Baffone W. Morphological changes and outer membrane protein patterns in Helicobacter pylori during conversion from bacillary to coccoid form. New Microbiol. 2004;27(4):353\u201360.","journal-title":"New Microbiol"},{"issue":"2","key":"704_CR116","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3748\/wjg.v7.i2.254","volume":"7","author":"F-F She","year":"2001","unstructured":"She F-F, Su D-H, Lin J-Y, Zhou L-Y. Virulence and potential pathogenicity of coccoid Helicobacter pylori induced by antibiotics. World J Gastroenterol. 2001;7(2):254.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"704_CR117","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13099-022-00488-y","volume":"14","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang S, Yang F, Chi W, Ding L, Liu T, Zhu F, Ji D, Zhou J, Fang Y. Antimicrobial resistance patterns and genetic elements associated with the antibiotic resistance of Helicobacter pylori strains from Shanghai. Gut pathogens. 2022;14(1):14.","journal-title":"Gut pathogens"},{"issue":"3","key":"704_CR118","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1073\/pnas.0407186102","volume":"102","author":"P Macheboeuf","year":"2005","unstructured":"Macheboeuf P, Di Guilmi AM, Job V, Vernet T, Dideberg O, Dessen A. Active site restructuring regulates ligand recognition in class A penicillin-binding proteins. Proc Natl Acad Sci USA. 2005;102(3):577\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"704_CR119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/mmi.14714","volume":"116","author":"D Straume","year":"2021","unstructured":"Straume D, Piechowiak KW, Kjos M, H\u00e5varstein LS. Class A PBPs: It is time to rethink traditional paradigms. Mol Microbiol. 2021;116(1):41\u201352.","journal-title":"Mol Microbiol"},{"issue":"6","key":"704_CR120","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.mib.2003.10.002","volume":"6","author":"DL Popham","year":"2003","unstructured":"Popham DL, Young KD. Role of penicillin-binding proteins in bacterial cell morphogenesis. Curr Opin Microbiol. 2003;6(6):594\u20139.","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"704_CR121","doi-asserted-by":"publisher","first-page":"12066","DOI":"10.1038\/s41598-024-62200-1","volume":"14","author":"JM Islam","year":"2024","unstructured":"Islam JM, Yano Y, Okamoto A, Matsuda R, Shiraishi M, Hashimoto Y, Morita N, Takeuchi H, Suganuma N, Takeuchi H. Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates. Sci Rep. 2024;14(1):12066.","journal-title":"Sci Rep"},{"issue":"6","key":"704_CR122","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jac\/dkf140","volume":"50","author":"T Okamoto","year":"2002","unstructured":"Okamoto T, Yoshiyama H, Nakazawa T, Park I-D, Chang M-W, Yanai H, Okita K, Shirai M. A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori. J Antimicrob Chemother. 2002;50(6):849\u201356.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"704_CR123","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1523-5378.2006.00398.x","volume":"11","author":"MM Gerrits","year":"2006","unstructured":"Gerrits MM, Godoy AP, Kuipers EJ, Ribeiro ML, Stoof J, Mendon\u00e7a S, Van Vliet AH, Pedrazzoli J Jr, Kusters JG. Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori. Helicobacter. 2006;11(3):181\u20137.","journal-title":"Helicobacter"},{"issue":"5","key":"704_CR124","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/jac\/dkn051","volume":"61","author":"E Rimbara","year":"2008","unstructured":"Rimbara E, Noguchi N, Kawai T, Sasatsu M. Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori. J Antimicrob Chemother. 2008;61(5):995\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"704_CR125","doi-asserted-by":"crossref","unstructured":"Alberts B: Molecular biology of the cell: Garland science; 2017.","DOI":"10.1201\/9781315735368"},{"issue":"1","key":"704_CR126","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1038\/s41467-019-13036-1","volume":"10","author":"JS Johnson","year":"2019","unstructured":"Johnson JS, Spakowicz DJ, Hong B-Y, Petersen LM, Demkowicz P, Chen L, Leopold SR, Hanson BM, Agresta HO, Gerstein M, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun. 2019;10(1):5029.","journal-title":"Nat Commun"},{"issue":"12","key":"704_CR127","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1128\/AAC.46.12.3940-3946.2002","volume":"46","author":"D Dailidiene","year":"2002","unstructured":"Dailidiene D, Bertoli MT, Miciuleviciene J, Mukhopadhyay AK, Dailide G, Pascasio MA, Kupcinskas L, Berg DE. Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother. 2002;46(12):3940\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"704_CR128","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1128\/JB.184.8.2131-2140.2002","volume":"184","author":"CA Trieber","year":"2002","unstructured":"Trieber CA, Taylor DE. Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol. 2002;184(8):2131\u201340.","journal-title":"J Bacteriol"},{"issue":"9","key":"704_CR129","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/AAC.46.9.2996-3000.2002","volume":"46","author":"MM Gerrits","year":"2002","unstructured":"Gerrits MM, de Zoete MR, Arents NL, Kuipers EJ, Kusters JG. 16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2002;46(9):2996\u20133000.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"704_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.45.1.1-12.2001","volume":"45","author":"B Vester","year":"2001","unstructured":"Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother. 2001;45(1):1\u201312.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"704_CR131","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.15537\/smj.2022.43.10.20220355","volume":"43","author":"KR Alkharsah","year":"2022","unstructured":"Alkharsah KR, Aljindan RY, Alamri AM, Alomar AI, Al-Quorain AA. Molecular characterization of Helicobacter pylori clinical isolates from Eastern Saudi Arabia. Saudi Med J. 2022;43(10):1128\u201335.","journal-title":"Saudi Med J"},{"key":"704_CR132","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2180-8-81","volume":"8","author":"Z Liu","year":"2008","unstructured":"Liu Z, Shen J, Zhang L, Shen L, Li Q, Zhang B, Zhou J, Gu L, Feng G, Ma J, et al. Prevalence of A2143G mutation of H pylori-23S rRNA in Chinese subjects with and without clarithromycin use history. BMC Microbio. 2008;8:81.","journal-title":"BMC Microbio"},{"issue":"7","key":"704_CR133","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1128\/JCM.39.7.2648-2651.2001","volume":"39","author":"A van der Ende","year":"2001","unstructured":"van der Ende A, van Doorn LJ, Rooijakkers S, Feller M, Tytgat GN, Dankert J. Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy. J Clin Microbiol. 2001;39(7):2648\u201351.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"704_CR134","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5009\/gnl220076","volume":"17","author":"JH Noh","year":"2023","unstructured":"Noh JH, Ahn JY, Choi J, Park YS, Na HK, Lee JH, Jung KW, Kim DH, Choi KD, Song HJ, et al. Real-time polymerase chain reaction for the detection of Helicobacter pylori and clarithromycin resistance. Gut Liver. 2023;17(3):375\u201381.","journal-title":"Gut Liver"},{"key":"704_CR135","doi-asserted-by":"crossref","unstructured":"Abd albagi SO, aldayem Altayeb HN, Khalil Abuzeid NM: Molecular detection and characterization of mutation on 23S rRNA gene associated with clarithromycin resistant in Helicobacter pylori. bioRxiv 2019:650432.","DOI":"10.1101\/650432"},{"key":"704_CR136","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.2147\/IDR.S372027","volume":"15","author":"MF El-Badawy","year":"2022","unstructured":"El-Badawy MF, Eed EM, Sleem AS, El-Sheikh AAK, Maghrabi IA, Abdelwahab SF. The first Saudi report of novel and common mutations in the gyrA and parC genes among Pseudomonas Spp. Clinical isolates recovered from Taif area. Infection Drug Resist. 2022;15:3801\u201314.","journal-title":"Infection Drug Resist"},{"issue":"1","key":"704_CR137","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1128\/AAC.05243-11","volume":"56","author":"M Garcia","year":"2012","unstructured":"Garcia M, Raymond J, Garnier M, Cremniter J, Burucoa C. Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France. Antimicrob Agents Chemother. 2012;56(1):550\u20131.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"704_CR138","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.05088-22","volume":"11","author":"J Thapa","year":"2023","unstructured":"Thapa J, Chizimu JY, Kitamura S, Akapelwa ML, Suwanthada P, Miura N, Toyting J, Nishimura T, Hasegawa N, Nishiuchi Y, et al. Characterization of DNA gyrase activity and elucidation of the impact of amino acid substitution in GyrA on fluoroquinolone resistance in Mycobacterium avium. Microbiology spectrum. 2023;11(3): e0508822.","journal-title":"Microbiology spectrum"},{"issue":"1","key":"704_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13099-019-0305-x","volume":"11","author":"V Shetty","year":"2019","unstructured":"Shetty V, Lamichhane B, Tay CY, Pai GC, Lingadakai R, Balaraju G, Shetty S, Ballal M, Chua EG. High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients. Gut pathogens. 2019;11(1):1\u20138.","journal-title":"Gut pathogens"},{"issue":"3","key":"704_CR140","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijantimicag.2014.10.019","volume":"45","author":"TN Phan","year":"2015","unstructured":"Phan TN, Santona A, Tran TNH, Cappuccinelli P, Rubino S, Paglietti B. High rate of levofloxacin resistance in a background of clarithromycin-and metronidazole-resistant Helicobacter pylori in Vietnam. Int J Antimicrob Agents. 2015;45(3):244\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"704_CR141","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ijantimicag.2006.11.007","volume":"29","author":"V Cattoir","year":"2007","unstructured":"Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier J-C, Megraud F, Soussy C-J, Cambau E. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents. 2007;29(4):389\u201396.","journal-title":"Int J Antimicrob Agents"},{"key":"704_CR142","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11518","volume":"9","author":"SM Puah","year":"2021","unstructured":"Puah SM, Goh KL, Ng HK, Chua KH. Current status of Helicobacter pylori resistance to Clarithromycin and Levofloxacin in Malaysia-findings from a molecular based study. PeerJ. 2021;9: e11518.","journal-title":"PeerJ"},{"issue":"1","key":"704_CR143","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1523-5378.2011.00912.x","volume":"17","author":"E Rimbara","year":"2012","unstructured":"Rimbara E, Noguchi N, Kawai T, Sasatsu M. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB. Helicobacter. 2012;17(1):36\u201342.","journal-title":"Helicobacter"},{"issue":"18","key":"704_CR144","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1073\/pnas.94.18.9608","volume":"94","author":"K Ma","year":"1997","unstructured":"Ma K, Hutchins A, Sung SJ, Adams MW. Pyruvate ferredoxin oxidoreductase from the hyperthermophilic archaeon, Pyrococcus furiosus, functions as a CoA-dependent pyruvate decarboxylase. Proc Natl Acad Sci USA. 1997;94(18):9608\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"704_CR145","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1021\/acscatal.1c00092","volume":"11","author":"B Li","year":"2021","unstructured":"Li B, Steindel P, Haddad N, Elliott SJ. Maximizing (Electro)catalytic CO2 reduction with a ferredoxin-based reduction potential gradient. ACS Catal. 2021;11(7):4009\u201323.","journal-title":"ACS Catal"},{"issue":"3","key":"704_CR146","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/biom3030578","volume":"3","author":"MS Eram","year":"2013","unstructured":"Eram MS, Ma K. Decarboxylation of pyruvate to acetaldehyde for ethanol production by hyperthermophiles. Biomolecules. 2013;3(3):578\u201396.","journal-title":"Biomolecules"},{"issue":"23","key":"704_CR147","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1128\/JB.01226-12","volume":"194","author":"JJ Gilbreath","year":"2012","unstructured":"Gilbreath JJ, West AL, Pich OQ, Carpenter BM, Michel S, Merrell DS. Fur activates expression of the 2-oxoglutarate oxidoreductase genes (oorDABC) in Helicobacter pylori. J Bacteriol. 2012;194(23):6490\u20137.","journal-title":"J Bacteriol"},{"issue":"3","key":"704_CR148","first-page":"410","volume":"47","author":"Z Su","year":"2006","unstructured":"Su Z, Xu H, Zhang C, Shao S, Li L, Wang H, Wang H, Qiu G. Mutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistance. Croat Med J. 2006;47(3):410\u20135.","journal-title":"Croat Med J"},{"issue":"37","key":"704_CR149","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.3748\/wjg.v23.i37.6920","volume":"23","author":"M Zamani","year":"2017","unstructured":"Zamani M, Rahbar A, Shokri-Shirvani J. Resistance of Helicobacter pylori to furazolidone and levofloxacin: a viewpoint. World J Gastroenterol. 2017;23(37):6920\u20132.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"704_CR150","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1128\/AAC.44.8.2133-2142.2000","volume":"44","author":"DH Kwon","year":"2000","unstructured":"Kwon DH, El-Zaatari FA, Kato M, Osato MS, Reddy R, Yamaoka Y, Graham DY. Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother. 2000;44(8):2133\u201342.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"704_CR151","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/jac\/dkaa302","volume":"75","author":"S Zhang","year":"2020","unstructured":"Zhang S, Wang X, Wise MJ, He Y, Chen H, Liu A, Huang H, Young S, Tay CY, Marshall BJ, et al. Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance. J Antimicrob Chemother. 2020;75(11):3152\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"704_CR152","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03903-22","volume":"11","author":"Y Gong","year":"2023","unstructured":"Gong Y, Zhai K, Sun L, He L, Wang H, Guo Y, Zhang J. RdxA diversity and mutations associated with metronidazole resistance of Helicobacter pylori. Microbiology spectrum. 2023;11(2): e0390322.","journal-title":"Microbiology spectrum"},{"issue":"17","key":"704_CR153","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1128\/JB.183.17.5155-5162.2001","volume":"183","author":"JY Jeong","year":"2001","unstructured":"Jeong JY, Mukhopadhyay AK, Akada JK, Dailidiene D, Hoffman PS, Berg DE. Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole. J Bacteriol. 2001;183(17):5155\u201362.","journal-title":"J Bacteriol"},{"issue":"7","key":"704_CR154","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/microorganisms8071062","volume":"8","author":"D Azzaya","year":"2020","unstructured":"Azzaya D, Gantuya B, Oyuntsetseg K, Davaadorj D, Matsumoto T, Akada J, Yamaoka Y. High antibiotic resistance of Helicobacter pylori and its associated novel gene mutations among the mongolian population. Microorganisms. 2020;8(7):1062.","journal-title":"Microorganisms"},{"issue":"3","key":"704_CR155","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1179\/136485911X12899838683485","volume":"105","author":"NF Tanih","year":"2011","unstructured":"Tanih NF, Ndip LM, Ndip RN. Characterisation of the genes encoding resistance to metronidazole (rdxA and frxA) and clarithromycin (the 23S-rRNA genes) in South African isolates of Helicobacter pylori. Ann Trop Med Parasitol. 2011;105(3):251\u20139.","journal-title":"Ann Trop Med Parasitol"},{"issue":"3","key":"704_CR156","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/clinids\/9.3.519","volume":"9","author":"RJ O'Brien","year":"1987","unstructured":"O\u2019Brien RJ, Lyle MA, Snider DE Jr. Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases. Rev Infect Dis. 1987;9(3):519\u201330.","journal-title":"Rev Infect Dis"},{"issue":"1","key":"704_CR157","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/clinids\/22.Supplement_1.S3","volume":"22","author":"CM Kunin","year":"1996","unstructured":"Kunin CM. Antimicrobial activity of rifabutin. Clin Infect Dise. 1996;22(1):S3-13.","journal-title":"Clin Infect Dise"},{"issue":"6","key":"704_CR158","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1128\/AAC.43.6.1497","volume":"43","author":"M Heep","year":"1999","unstructured":"Heep M, Beck D, Bayerd\u00f6rffer E, Lehn N. Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob Agents Chemother. 1999;43(6):1497\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"704_CR159","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1128\/AAC.45.3.727-733.2001","volume":"45","author":"G Wang","year":"2001","unstructured":"Wang G, Wilson TJ, Jiang Q, Taylor DE. Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2001;45(3):727\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"704_CR160","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/jac\/dkm039","volume":"59","author":"E Glocker","year":"2007","unstructured":"Glocker E, Bogdan C, Kist M. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. J Antimicrob Chemother. 2007;59(5):874\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"704_CR161","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/hel.12299","volume":"21","author":"Y Hu","year":"2016","unstructured":"Hu Y, Zhang M, Lu B, Dai J. Helicobacter pylori and antibiotic resistance, a continuing and intractable problem. Helicobacter. 2016;21(5):349\u201363.","journal-title":"Helicobacter"},{"issue":"5","key":"704_CR162","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S1568-7864(03)00024-7","volume":"2","author":"L Garibyan","year":"2003","unstructured":"Garibyan L, Huang T, Kim M, Wolff E, Nguyen A, Nguyen T, Diep A, Hu K, Iverson A, Yang H, et al. Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair. 2003;2(5):593\u2013608.","journal-title":"DNA Repair"},{"issue":"4","key":"704_CR163","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1128\/AAC.44.4.1075-1077.2000","volume":"44","author":"M Heep","year":"2000","unstructured":"Heep M, Rieger U, Beck D, Lehn N. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2000;44(4):1075\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"704_CR164","doi-asserted-by":"publisher","first-page":"e12451","DOI":"10.1111\/hel.12451","volume":"23","author":"C Hays","year":"2018","unstructured":"Hays C, Burucoa C, Lehours P, Tran CT, Leleu A, Raymond J. Molecular characterization of Helicobacter pylori resistance to rifamycins. Helicobacter. 2018;23(1):e12451.","journal-title":"Helicobacter"},{"issue":"2","key":"704_CR165","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/antibiotics12020191","volume":"12","author":"A Elbehiry","year":"2023","unstructured":"Elbehiry A, Marzouk E, Aldubaib M, Abalkhail A, Anagreyyah S, Anajirih N, Almuzaini AM, Rawway M, Alfadhel A, Draz A, et al. Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic and control challenges. Antibiotics. 2023;12(2):191.","journal-title":"Antibiotics"},{"issue":"5","key":"704_CR166","doi-asserted-by":"publisher","first-page":"1700845","DOI":"10.1002\/adhm.201700845","volume":"7","author":"VF Cardoso","year":"2018","unstructured":"Cardoso VF, Francesko A, Ribeiro C, Ba\u00f1obre-L\u00f3pez M, Martins P, Lanceros-Mendez S. Advances in magnetic nanoparticles for biomedical applications. Adv Healthcare Mater. 2018;7(5):1700845.","journal-title":"Adv Healthcare Mater"},{"issue":"7354","key":"704_CR167","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/bmj.325.7354.3","volume":"325","author":"PJ Jenks","year":"2002","unstructured":"Jenks PJ. Causes of failure of eradication of Helicobacter pylori. BMJ. 2002;325(7354):3\u20134.","journal-title":"BMJ"},{"issue":"13","key":"704_CR168","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3390\/healthcare11131946","volume":"11","author":"MA Salam","year":"2023","unstructured":"Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MAA. Antimicrobial resistance: a growing serious threat for global public health. Healthcare. 2023;11(13):1946.","journal-title":"Healthcare"},{"issue":"14","key":"704_CR169","doi-asserted-by":"publisher","first-page":"11708","DOI":"10.3390\/ijms241411708","volume":"24","author":"HY Ng","year":"2023","unstructured":"Ng HY, Leung WK, Cheung KS. Antibiotic resistance, susceptibility testing and stewardship in Helicobacter pylori infection. Int J Mol Sci. 2023;24(14):11708.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"704_CR170","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.gheart.2014.08.009","volume":"9","author":"LM Bebell","year":"2014","unstructured":"Bebell LM, Muiru AN. Antibiotic use and emerging resistance: how can resource-limited countries turn the tide? Glob Heart. 2014;9(3):347\u201358.","journal-title":"Glob Heart"},{"issue":"35","key":"704_CR171","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e278","volume":"38","author":"CH Park","year":"2023","unstructured":"Park CH, Jung SY, Lee JW, Yang HJ, Kim JS, Kim BJ, Choi SI, Seo SI, Lee J, Kim JG. Developing operational definitions related to Helicobacter pylori eradication therapy. J Korean Med Sci. 2023;38(35): e278.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"704_CR172","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1756283X09337342","volume":"2","author":"JP O'Connor","year":"2009","unstructured":"O\u2019Connor JP, Taneike I, O\u2019Morain C. Improving compliance with Helicobacter pylori eradication therapy: when and how? Ther Adv Gastroenterol. 2009;2(5):273\u20139.","journal-title":"Ther Adv Gastroenterol"},{"issue":"8","key":"704_CR173","volume":"15","author":"R Rammohan","year":"2023","unstructured":"Rammohan R, Magam SG, Joy M, Natt D, Patel A, Tadikonda A, Desai J, Bunting S, Yost RM, Akande O, et al. Unpacking the racial gap: Helicobacter pylori infection clearance among different racial groups. Cureus. 2023;15(8): e43080.","journal-title":"Cureus"},{"issue":"1","key":"704_CR174","first-page":"3","volume":"4","author":"MR Zali","year":"2011","unstructured":"Zali MR. Facing resistance of H.pylori infection. Gastroenterol Hepatol Bed Bench. 2011;4(1):3\u201311.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"1","key":"704_CR175","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/antibiotics12010146","volume":"12","author":"F Galo\u0219","year":"2023","unstructured":"Galo\u0219 F, Boboc C, Ie\u0219anu MI, Anghel M, Ioan A, Iana E, Co\u0219oreanu MT, Boboc AA. Antibiotic resistance and therapeutic efficacy of Helicobacter pylori infection in pediatric patients-a tertiary center experience. Antibiotics. 2023;12(1):146.","journal-title":"Antibiotics"},{"issue":"2","key":"704_CR176","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1128\/CMR.00033-06","volume":"20","author":"F M\u00e9graud","year":"2007","unstructured":"M\u00e9graud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20(2):280\u2013322.","journal-title":"Clin Microbiol Rev"},{"key":"704_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.801537","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Huang Y, Ding Z, Liang X, Lu H. E-test or agar dilution for metronidazole susceptibility testing of Helicobacter pylori: importance of the prevalence of metronidazole resistance. Front Microbiol. 2022;13: 801537.","journal-title":"Front Microbiol"},{"issue":"16","key":"704_CR178","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.3748\/wjg.v23.i16.2854","volume":"23","author":"N Arslan","year":"2017","unstructured":"Arslan N, Y\u0131lmaz \u00d6, Demiray-G\u00fcrb\u00fcz E. Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection. World J Gastroenterol. 2017;23(16):2854\u201369.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"704_CR179","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43(4):514\u201333.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"704_CR180","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3855\/jidc.6942","volume":"9","author":"TN Phan","year":"2015","unstructured":"Phan TN, Tran VH, Tran TN, Le VA, Santona A, Rubino S, Paglietti B. Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam. J Infect Dev Ctries. 2015;9(6):609\u201313.","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"704_CR181","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13104-019-4877-9","volume":"13","author":"M Miftahussurur","year":"2020","unstructured":"Miftahussurur M, Fauzia KA, Nusi IA, Setiawan PB, Syam AF, Waskito LA, Doohan D, Ratnasari N, Khomsan A, Adnyana IK, et al. E-test versus agar dilution for antibiotic susceptibility testing of Helicobacter pylori: a comparison study. BMC Res Notes. 2020;13(1):22.","journal-title":"BMC Res Notes"},{"issue":"32","key":"704_CR182","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.3748\/wjg.v25.i32.4629","volume":"25","author":"D Pohl","year":"2019","unstructured":"Pohl D, Keller PM, Bordier V, Wagner K. Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing. World J Gastroenterol. 2019;25(32):4629\u201360.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"704_CR183","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/antibiotics10020209","volume":"10","author":"GD Kaprou","year":"2021","unstructured":"Kaprou GD, Berg\u0161pica I, Alexa EA, Alvarez-Ord\u00f3\u00f1ez A, Prieto M. Rapid methods for antimicrobial resistance diagnostics. Antibiotics. 2021;10(2):209.","journal-title":"Antibiotics"},{"issue":"6","key":"704_CR184","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000184","volume":"11","author":"MJ Ram\u00edrez-L\u00e1zaro","year":"2020","unstructured":"Ram\u00edrez-L\u00e1zaro MJ, Lario S, Qu\u00edlez ME, Montserrat A, Bella MR, Junquera F, Garc\u00eda-Mart\u00ednez L, Casalots \u00c0, Parra T, Calvet X. Droplet digital PCR detects low-density infection in a significant proportion of Helicobacter pylori-negative gastric biopsies of dyspeptic patients. Clin Transl Gastroenterol. 2020;11(6): e00184.","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"704_CR185","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3748\/wjg.v11.i3.382","volume":"11","author":"HJ Lin","year":"2005","unstructured":"Lin HJ, Lo WC, Perng CL, Tseng GY, Li AF, Ou YH. Mucosal polymerase chain reaction for diagnosing Helicobacter pylori infection in patients with bleeding peptic ulcers. World J Gastroenterol. 2005;11(3):382\u20135.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"704_CR186","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1128\/JCM.40.10.3720-3728.2002","volume":"40","author":"Q He","year":"2002","unstructured":"He Q, Wang JP, Osato M, Lachman LB. Real-time quantitative PCR for detection of Helicobacter pylori. J Clin Microbiol. 2002;40(10):3720\u20138.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"704_CR187","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1309\/APMPEP54G7PN958G","volume":"129","author":"J Weiss","year":"2008","unstructured":"Weiss J, Tsang TK, Meng X, Zhang H, Kilner E, Wang E, Watkin W. Detection of Helicobacter pylori gastritis by PCR: correlation with inflammation scores and immunohistochemical and CLOtest findings. Am J Clin Pathol. 2008;129(1):89\u201396.","journal-title":"Am J Clin Pathol"},{"key":"704_CR188","doi-asserted-by":"publisher","first-page":"898276","DOI":"10.1155\/2012\/898276","volume":"2012","author":"T Chen","year":"2012","unstructured":"Chen T, Meng X, Zhang H, Tsang RW, Tsang TK. Comparing multiplex PCR and rapid urease test in the detection of H. pylori in patients on proton pump inhibitors. Gastroenterol Res Pract. 2012;2012:898276.","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"704_CR189","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1073\/pnas.0506655103","volume":"103","author":"EM Bik","year":"2006","unstructured":"Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA. 2006;103(3):732\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"704_CR190","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/IAI.00031-17","volume":"85","author":"K Thorell","year":"2017","unstructured":"Thorell K, Bengtsson-Palme J, Liu OH, Palacios Gonzales RV, Nookaew I, Rabeneck L, Paszat L, Graham DY, Nielsen J, Lundin SB, et al. In vivo analysis of the viable microbiota and Helicobacter pylori transcriptome in gastric infection and early stages of carcinogenesis. Infect Immunit. 2017;85(10):10\u2013128.","journal-title":"Infect Immunit"},{"issue":"1","key":"704_CR191","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/JCM.38.1.13-17.2000","volume":"38","author":"LJ van Doorn","year":"2000","unstructured":"van Doorn LJ, Henskens Y, Nouhan N, Verschuuren A, Vreede R, Herbink P, Ponjee G, van Krimpen K, Blankenburg R, Scherpenisse J, et al. The efficacy of laboratory diagnosis of Helicobacter pylori infections in gastric biopsy specimens is related to bacterial density and vacA, cagA, and iceA genotypes. J Clin Microbiol. 2000;38(1):13\u20137.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"704_CR192","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/s18041271","volume":"18","author":"PL Quan","year":"2018","unstructured":"Quan PL, Sauzade M, Brouzes E. dPCR: a technology review. Sensors. 2018;18(4):1271.","journal-title":"Sensors"},{"issue":"10","key":"704_CR193","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nmeth.2633","volume":"10","author":"CM Hindson","year":"2013","unstructured":"Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, Vessella RL, Tewari M. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 2013;10(10):1003\u20135.","journal-title":"Nat Methods"},{"key":"704_CR194","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bios.2016.09.082","volume":"90","author":"L Cao","year":"2017","unstructured":"Cao L, Cui X, Hu J, Li Z, Choi JR, Yang Q, Lin M, Ying Hui L, Xu F. Advances in digital polymerase chain reaction (dPCR) and its emerging biomedical applications. Biosens Bioelectron. 2017;90:459\u201374.","journal-title":"Biosens Bioelectron"},{"issue":"4","key":"704_CR195","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/hel.12289","volume":"21","author":"S Talarico","year":"2016","unstructured":"Talarico S, Safaeian M, Gonzalez P, Hildesheim A, Herrero R, Porras C, Cortes B, Larson A, Fang FC, Salama NR. Quantitative detection and genotyping of Helicobacter pylori from stool using droplet digital PCR reveals variation in bacterial loads that correlates with cagA virulence gene carriage. Helicobacter. 2016;21(4):325\u201333.","journal-title":"Helicobacter"},{"issue":"9","key":"704_CR196","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JCM.00019-18","volume":"56","author":"L Sun","year":"2018","unstructured":"Sun L, Talarico S, Yao L, He L, Self S, You Y, Zhang H, Zhang Y, Guo Y, Liu G, et al. Droplet digital PCR-based detection of clarithromycin resistance in Helicobacter pylori isolates reveals frequent Heteroresistance. J Clin Microbiol. 2018;56(9):10\u2013128.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"704_CR197","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12472","volume":"23","author":"S Talarico","year":"2018","unstructured":"Talarico S, Korson AS, Leverich CK, Park S, Jalikis FG, Upton MP, Broussard E, Salama NR. High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. Helicobacter. 2018;23(2): e12472.","journal-title":"Helicobacter"},{"issue":"1","key":"704_CR198","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jac\/dky401","volume":"74","author":"MR Ram","year":"2019","unstructured":"Ram MR, Teh X, Rajakumar T, Goh KL, Leow AHR, Poh BH, Mariappan V, Shankar EM, Loke MF, Vadivelu J. Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy. J Antimicrob Chemother. 2019;74(1):11\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"704_CR199","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/hel.12289","volume":"21","author":"S Talarico","year":"2015","unstructured":"Talarico S, Safaeian M, Gonz\u00e1lez P, Hildesheim A, Porras C, Cortes B, Larson A, Fang F, Salama N. Quantitative detection and genotyping of Helicobacter pylori from stool using droplet digital pcr reveals variation in bacterial loads that correlates with cagA virulence gene carriage. Helicobacter. 2015;21:325\u201333.","journal-title":"Helicobacter"},{"issue":"5","key":"704_CR200","volume":"15","author":"NA Urgessa","year":"2023","unstructured":"Urgessa NA, Geethakumari P, Kampa P, Parchuri R, Bhandari R, Alnasser AR, Akram A, Kar S, Osman F, Mashat GD, et al. A comparison between histology and rapid urease test in the diagnosis of Helicobacter pylori in gastric biopsies: a systematic review. Cureus. 2023;15(5): e39360.","journal-title":"Cureus"},{"issue":"1","key":"704_CR201","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41467-020-16731-6","volume":"11","author":"K Kiga","year":"2020","unstructured":"Kiga K, Tan XE, Ibarra-Ch\u00e1vez R, Watanabe S, Aiba Y, Sato\u2019o Y, Li FY, Sasahara T, Cui B, Kawauchi M, et al. Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Nat Commun. 2020;11(1):2934.","journal-title":"Nat Commun"},{"issue":"7","key":"704_CR202","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","volume":"9","author":"A Mayorga-Ramos","year":"2023","unstructured":"Mayorga-Ramos A, Z\u00fa\u00f1iga-Miranda J, Carrera-Pacheco SE, Barba-Ostria C, Guam\u00e1n LP. CRISPR-cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance. ACS Infect Dis. 2023;9(7):1283\u2013302.","journal-title":"ACS Infect Dis"},{"issue":"12","key":"704_CR203","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.3390\/jpm12122082","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Liu L, Liu X, Wu K, Zhu X, Ma L, Su J. An ultrasensitive PCR-Based CRISPR-Cas13a method for the detection of Helicobacter pylori. J Personal Med. 2022;12(12):2082.","journal-title":"J Personal Med"},{"key":"704_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2022.340736","volume":"1239","author":"X Zhang","year":"2023","unstructured":"Zhang X, Qiu H, Zhong X, Yi S, Jia Z, Chen L, Hu S. A CRISPR\/Cas12a-assisted array for Helicobacter pylori DNA analysis in saliva. Anal Chim Acta. 2023;1239: 340736.","journal-title":"Anal Chim Acta"},{"issue":"4","key":"704_CR205","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/ph16040552","volume":"16","author":"A Sukri","year":"2023","unstructured":"Sukri A, Hanafiah A, Patil S, Lopes BS. The potential of alternative therapies and vaccine candidates against Helicobacter pylori. Pharmaceuticals. 2023;16(4):552.","journal-title":"Pharmaceuticals"},{"key":"704_CR206","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.25.542131","author":"JA Bugaytsova","year":"2023","unstructured":"Bugaytsova JA, Piddubnyi A, Tkachenko I, Rakhimova L, Edlund JO, Thorell K, Marcotte H, Lundquist A, Sch\u00f6n K, Lycke N, et al. Vaccination with Helicobacter pylori attachment proteins protects against gastric cancer. BioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.05.25.542131.","journal-title":"BioRxiv"},{"issue":"50","key":"704_CR207","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1016\/j.vaccine.2018.01.001","volume":"37","author":"P Sutton","year":"2019","unstructured":"Sutton P, Boag JM. Status of vaccine research and development for Helicobacter pylori. Vaccine. 2019;37(50):7295\u20139.","journal-title":"Vaccine"},{"key":"704_CR208","first-page":"1","volume":"27","author":"FH Haghighi","year":"2024","unstructured":"Haghighi FH, Menbari S, Mohammadzadeh R, Pishdadian A, Farsiani H. Developing a potent vaccine against Helicobacter pylori: critical considerations and challenges. Expert Rev Mol Med. 2024;27:1\u201361.","journal-title":"Expert Rev Mol Med"},{"key":"704_CR209","doi-asserted-by":"publisher","first-page":"918160","DOI":"10.3389\/fimmu.2022.918160","volume":"13","author":"L Guo","year":"2022","unstructured":"Guo L, Zhang F, Wang S, Li R, Zhang L, Zhang Z, Yin R, Liu H, Liu K. Oral immunization with a M cell-targeting recombinant L. Lactis vaccine LL-plSAM-FVpE stimulate protective immunity against H. pylori in Mice. Front Immunol. 2022;13:918160.","journal-title":"Front Immunol"},{"issue":"7","key":"704_CR210","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/vaccines11071232","volume":"11","author":"KW Kwong","year":"2023","unstructured":"Kwong KW, Xin Y, Lai NC, Sung JC, Wu KC, Hamied YK, Sze ET, Lam DM. Oral vaccines: a better future of immunization. Vaccines. 2023;11(7):1232.","journal-title":"Vaccines"},{"key":"704_CR211","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.addr.2017.04.008","volume":"114","author":"JE Vela Ramirez","year":"2017","unstructured":"Vela Ramirez JE, Sharpe LA, Peppas NA. Current state and challenges in developing oral vaccines. Adv Drug Deliv Rev. 2017;114:116\u201331.","journal-title":"Adv Drug Deliv Rev"},{"key":"704_CR212","doi-asserted-by":"crossref","unstructured":"Carneiro FA, Cortines JdR, Essus VA, da Silva IBN: Chapter 4 - Vaccine engineering & structural vaccinology. In: System Vaccinology. Edited by Prajapati V: Academic Press; 2022: 55\u201386.","DOI":"10.1016\/B978-0-323-85941-7.00005-X"},{"issue":"11","key":"704_CR213","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/eji.201141592","volume":"41","author":"SH Kim","year":"2011","unstructured":"Kim SH, Jung DI, Yang IY, Kim J, Lee KY, Nochi T, Kiyono H, Jang YS. M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery. Eur J Immunol. 2011;41(11):3219\u201329.","journal-title":"Eur J Immunol"},{"issue":"45","key":"704_CR214","doi-asserted-by":"publisher","first-page":"30585","DOI":"10.1074\/jbc.M803548200","volume":"283","author":"J Ling","year":"2008","unstructured":"Ling J, Liao H, Clark R, Wong MS, Lo DD. Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance. J Biol Chem. 2008;283(45):30585\u201395.","journal-title":"J Biol Chem"},{"issue":"30","key":"704_CR215","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1016\/j.biomaterials.2010.06.059","volume":"31","author":"MK Yoo","year":"2010","unstructured":"Yoo MK, Kang SK, Choi JH, Park IK, Na HS, Lee HC, Kim EB, Lee NK, Nah JW, Choi YJ, et al. Targeted delivery of chitosan nanoparticles to Peyer\u2019s patch using M cell-homing peptide selected by phage display technique. Biomaterials. 2010;31(30):7738\u201347.","journal-title":"Biomaterials"},{"issue":"2","key":"704_CR216","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/antibiotics12020274","volume":"12","author":"YA Helmy","year":"2023","unstructured":"Helmy YA, Taha-Abdelaziz K, Hawwas HAE-H, Ghosh S, AlKafaas SS, Moawad MMM, Saied EM, Kassem II, Mawad AMM. Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens. Antibiotics. 2023;12(2):274.","journal-title":"Antibiotics"},{"key":"704_CR217","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.intimp.2019.05.015","volume":"73","author":"EPV Pereira","year":"2019","unstructured":"Pereira EPV, van Tilburg MF, Florean E, Guedes MIF. Egg yolk antibodies (IgY) and their applications in human and veterinary health: a review. Int Immunopharmacol. 2019;73:293\u2013303.","journal-title":"Int Immunopharmacol"},{"key":"704_CR218","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fnut.2018.00052","volume":"5","author":"LH Ulfman","year":"2018","unstructured":"Ulfman LH, Leusen JHW, Savelkoul HFJ, Warner JO, van Neerven RJJ. Effects of bovine immunoglobulins on immune function, allergy, and infection. Front Nutr. 2018;5:52.","journal-title":"Front Nutr"},{"key":"704_CR219","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12937-015-0067-3","volume":"14","author":"S M\u00fcller","year":"2015","unstructured":"M\u00fcller S, Schubert A, Zajac J, Dyck T, Oelkrug C. IgY antibodies in human nutrition for disease prevention. Nutr J. 2015;14:109.","journal-title":"Nutr J"},{"issue":"5","key":"704_CR220","first-page":"1061","volume":"9","author":"JH Shin","year":"2002","unstructured":"Shin JH, Yang M, Nam SW, Kim JT, Myung NH, Bang WG, Roe IH. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin Diagn Lab Immunol. 2002;9(5):1061\u20136.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Suppl 1","key":"704_CR221","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2036.2004.02027.x","volume":"20","author":"H Suzuki","year":"2004","unstructured":"Suzuki H, Nomura S, Masaoka T, Goshima H, Kamata N, Kodama Y, Ishii H, Kitajima M, Nomoto K, Hibi T. Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection. Aliment Pharmacol Ther. 2004;20(Suppl 1):185\u201392.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"704_CR222","doi-asserted-by":"publisher","first-page":"e12843","DOI":"10.1111\/hel.12843","volume":"26","author":"R Guo","year":"2021","unstructured":"Guo R, Wu S, Guan L, Xie Y, Yang X, Li Z, Zhang Z. Dietary multivalent anti-Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients. Helicobacter. 2021;26(5):e12843.","journal-title":"Helicobacter"},{"issue":"2","key":"704_CR223","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7774\/cevr.2015.4.2.177","volume":"4","author":"K Borhani","year":"2015","unstructured":"Borhani K, Mobarez AM, Khabiri AR, Behmanesh M, Khoramabadi N. Production of specific IgY Helicobacter pylori recombinant OipA protein and assessment of its inhibitory effects towards attachment of H. pylori to AGS cell line. Clin Exp Vacc Res. 2015;4(2):177\u201383.","journal-title":"Clin Exp Vacc Res"},{"key":"704_CR224","doi-asserted-by":"publisher","first-page":"1065353","DOI":"10.3389\/fimmu.2023.1065353","volume":"14","author":"SA El-Kafrawy","year":"2023","unstructured":"El-Kafrawy SA, Abbas AT, Oelkrug C, Tahoon M, Ezzat S, Zumla A, Azhar EI. IgY antibodies: the promising potential to overcome antibiotic resistance. Front Immunol. 2023;14:1065353.","journal-title":"Front Immunol"},{"issue":"4","key":"704_CR225","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1155\/2011\/672093","volume":"25","author":"CM den Hoed","year":"2011","unstructured":"den Hoed CM, de Vries AC, Mensink PB, Dierikx CM, Suzuki H, Capelle L, van Dekken H, Ouwendijk R, Kuipers EJ. Bovine antibody-based oral immunotherapy for reduction of intragastric Helicobacter pylori colonization: a randomized clinical trial. Canadian J Gastroenterol. 2011;25(4):207\u201313.","journal-title":"Canadian J Gastroenterol"},{"issue":"8863","key":"704_CR226","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0140-6736(93)91327-I","volume":"342","author":"JE Thomas","year":"1993","unstructured":"Thomas JE, Austin S, Dale A, McClean P, Harding M, Coward WA, Weaver LT. Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet. 1993;342(8863):121.","journal-title":"Lancet"},{"issue":"6","key":"704_CR227","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1365-2036.1998.00335.x","volume":"12","author":"TH Casswall","year":"1998","unstructured":"Casswall TH, Sarker SA, Albert MJ, Fuchs GJ, Bergstr\u00f6m M, Bj\u00f6rck L, Hammarstr\u00f6m L. Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Aliment Pharmacol Ther. 1998;12(6):563\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"704_CR228","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1080\/003655202762671242","volume":"37","author":"TH Casswall","year":"2002","unstructured":"Casswall TH, Nilsson HO, Bj\u00f6rck L, Sj\u00f6stedt S, Xu L, Nord CK, Bor\u00e9n T, Wadstr\u00f6m T, Hammarstr\u00f6m L. Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scand J Gastroenterol. 2002;37(12):1380\u20135.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"704_CR229","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13067","volume":"29","author":"MH Peypar","year":"2024","unstructured":"Peypar MH, Yeganeh AV, Ramazani A, Alizadeh A, Abdorrashidi M, Tohidinia A, Shamlou MM, Heiat M. Oral immunotherapy for Helicobacter pylori: can it be trusted? A systematic review. Helicobacter. 2024;29(2): e13067.","journal-title":"Helicobacter"},{"key":"704_CR230","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.2147\/IJN.S405052","volume":"18","author":"X Yin","year":"2023","unstructured":"Yin X, Lai Y, Du Y, Zhang T, Gao J, Li Z. Metal-based nanoparticles: a prospective strategy for Helicobacter pylori treatment. Int J Nanomed. 2023;18:2413\u201329.","journal-title":"Int J Nanomed"},{"key":"704_CR231","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4103\/jehp.jehp_557_21","volume":"10","author":"MB Sannathimmappa","year":"2021","unstructured":"Sannathimmappa MB, Nambiar V, Aravindakshan R. Antibiotics at the crossroads\u2013do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? J Educat Health Promot. 2021;10:438.","journal-title":"J Educat Health Promot"},{"key":"704_CR232","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang L, Hu C, Shao L. The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomed. 2017;12:1227\u201349.","journal-title":"Int J Nanomed"},{"issue":"2","key":"704_CR233","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/ma15020427","volume":"15","author":"A Naganthran","year":"2022","unstructured":"Naganthran A, Verasoundarapandian G, Khalid FE, Masarudin MJ, Zulkharnain A, Nawawi NM, Karim M, Che Abdullah CA, Ahmad SA. Synthesis, characterization and biomedical application of silver nanoparticles. Materials. 2022;15(2):427.","journal-title":"Materials"},{"issue":"3","key":"704_CR234","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40204-020-00135-2","volume":"9","author":"D Garg","year":"2020","unstructured":"Garg D, Sarkar A, Chand P, Bansal P, Gola D, Sharma S, Khantwal S, Surabhi H, Mehrotra R, Chauhan N, et al. Synthesis of silver nanoparticles utilizing various biological systems: mechanisms and applications-a review. Progress Biomater. 2020;9(3):81\u201395.","journal-title":"Progress Biomater"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00704-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T09:03:55Z","timestamp":1747991035000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-025-00704-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":234,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00704-5","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}